Wednesday, August 12, 2020 7:11:32 AM
❗️Off-label use of RLF 100 in India.
— Siddhartha| सिद्धार्थ| సిద్ధార్థ (@das_seed) August 11, 2020
NeuroRx has been granted Investigational New Drug (IND) permission by @US_FDA to test RLF-100 for inhaled use in patients with moderate and severe #COVID19 in order to prevent progression to respiratory failure. 🧐
Image via @sandhyafernez pic.twitter.com/jMOcCrTq8A
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM